Related references
Note: Only part of the references are listed.2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Lisa G. Rider et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial
Nicolino Ruperto et al.
LANCET (2016)
Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises
Hugh de Lautour et al.
ARTHRITIS CARE & RESEARCH (2016)
Treatment of inflammatory myopathy: emerging therapies and therapeutic targets
Siamak Moghadam-Kia et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
2015 Gout Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Tuhina Neogi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Validation of the Auto-Inflammatory Diseases Activity Index (AIDAI) for hereditary recurrent fever syndromes
Maryam Piram et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Rohit Aggarwal et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria
Sindhu R. Johnson et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
Patient-reported Outcomes and Adult Patients' Disease Experience in the Idiopathic Inflammatory Myopathies. Report from the OMERACT 11 Myositis Special Interest Group
Helene Alexanderson et al.
JOURNAL OF RHEUMATOLOGY (2014)
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
Kathrin S. Utz et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2014)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis A Randomized, Placebo-Phase Trial
Chester V. Oddis et al.
ARTHRITIS AND RHEUMATISM (2013)
Do Patient Preferences for Core Outcome Domains for Chronic Gout Studies Support the Validity of Composite Response Criteria?
William J. Taylor et al.
ARTHRITIS CARE & RESEARCH (2013)
Discrete choice experiments in health economics: a review of the literature
Esther W. de Bekker-Grob et al.
HEALTH ECONOMICS (2012)
A Randomized, Pilot Trial of Etanercept in Dermatomyositis The Muscle Study Group
Anthony A. Amato et al.
ANNALS OF NEUROLOGY (2011)
Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO)
Nicolino Ruperto et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2011)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ARTHRITIS AND RHEUMATISM (2011)
Deciphering the Clinical Presentations, Pathogenesis, and Treatment of the Idiopathic Inflammatory Myopathies
Lisa G. Rider et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Bringing It All Together: A Novel Approach to the Development of Response Criteria for Chronic Gout Clinical Trials
William J. Taylor et al.
JOURNAL OF RHEUMATOLOGY (2011)
Methods of Formal Consensus in Classification/Diagnostic Criteria and Guideline Development
Raj Nair et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation
Nicolino Ruperto et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The 2010 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Rheumatoid Arthritis Phase 2 Methodological Report
Tuhina Neogi et al.
ARTHRITIS AND RHEUMATISM (2010)
Health-Related Quality of Life of Patients With Juvenile Dermatomyositis: Results From the Paediatric Rheumatology International Trials Organisation Multinational Quality of Life Cohort Study
Maria Teresa Apaz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Consensus procedures and their role in pediatric rheumatology
Nicolino Ruperto et al.
Current Rheumatology Reports (2008)
A New Method for Scoring Additive Multi- attributeValue Models Using Pairwise Rankings of Alternatives
Paul Hansen et al.
JOURNAL OF MULTI-CRITERIA DECISION ANALYSIS (2008)
The Provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: A prospective validation study
Nicolino Ruperto et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
A proposed revision to the ACR20:: The hybrid measure of American College of Rheumatology response
David Felson et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy
G. J. D. Hengstman et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
International consensus on preliminary definitions of improvement in adult and juvenile myositis
LG Rider et al.
ARTHRITIS AND RHEUMATISM (2004)
Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies
LG Rider
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2002)
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies
FW Miller et al.
RHEUMATOLOGY (2001)
Share Paper
